Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine dose reduction in kidney transplant
NCT00518375Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2000
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 4 trial of cyclosporine in kidney transplant rejection, sponsored by Pfizer. Started Apr 2000; status: completed.
02
Drugs
cyclosporine
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00518375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518375.